Yuce Biotechnology - About the company
Yuce Biotechnology is a series B company based in Shenzhen (China), founded in 2015 by Gao Zhibo. It operates as a Developer of gene detection services for precise immunotherapy of tumors. Yuce Biotechnology has raised an undisclosed amount in funding from IDG Capital. The company has 575 active competitors, including 90 funded and 33 that have exited. Its top competitors include companies like Benchling, Helix and Formation Bio.
Company Details
Developer of gene detection services for precise immunotherapy of tumors. The company has developed an oncology drug using public data sources and mutation analysis modules. The flagship product, TrueNeon is artificial intelligence (AI) based tumor neoplastic antigen prediction technology based on tumor exon and transcriptome data. The company is using the TrueNeone platform for biomarker development, personalized cancer vaccines, and personalized cell therapy development. The company has also developed a tumor immunotherapy (IO) clinical trial navigation portal.
- Website
- www.yucebio.com
- Email ID
- *****@yucebio.com
- Phone Number
- +86 **********
Key Metrics
Founded Year
2015
Location
Shenzhen, China
Stage
Series B
Latest Funding Round
Investors
Ranked
148th among 575 active competitors
Employee Count
37 as on Aug 31, 2026
Similar Companies
Sign up to download Yuce Biotechnology's company profile
Yuce Biotechnology's funding and investors
Yuce Biotechnology has raised funding over 2 rounds. Its first funding round was on Mar 2018. Its latest funding round was a Series B round on Dec 10, 2018 for $*****. 1 investor participated in its latest round. Yuce Biotechnology has 4 institutional investors.
Here is the list of recent funding rounds of Yuce Biotechnology:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Dec 10, 2018 | 7136123 | Series B | 4719266 | 4995690 | 2947963 | 3746006 |
Mar 2018 | 4153292 | Seed | 9695804 | 6594315 | 7491931 |
Access funding benchmarks and valuations. Sign up today!View details of Yuce Biotechnology's funding rounds and investors
Yuce Biotechnology's founders and board of directors
Founder? Claim ProfileHere are the details of Yuce Biotechnology's key team members:
- Gao Zhibo: Founder & CEO of Yuce Biotechnology.
View details of Yuce Biotechnology's Founder profiles and Board Members
Yuce Biotechnology's employee count trend
Yuce Biotechnology has 37 employees as of Aug 26. Here is Yuce Biotechnology's employee count trend over the years:
Uncover Yuce Biotechnology's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Yuce Biotechnology's Competitors and alternates
Top competitors of Yuce Biotechnology include Benchling, Helix and Formation Bio. Here is the list of Top 10 competitors of Yuce Biotechnology, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Benchling 2012, San Francisco (United States), Series F | Provider of a cloud-based bioinformatics platform for biotech research | $412M | 73/100 | |
2nd |  Helix 2015, San Francisco (United States), Series E | Provider of a genomic database for clinical research | $435M | 71/100 | |
3rd |  Formation Bio 2016, New York City (United States), Series D | Provider of AI-powered drug discovery platform for various diseases | $608M | 70/100 | |
4th | Sophia Genetics 2011, Rolle (Switzerland), Public | Provider of artificial intelligence software for analyzing complex medical data | $249M | 62/100 | |
5th |  Cellarity 2015, Cambridge (United States), Series C | AI-powered drug design and development platform | $294M | 61/100 | |
6th |  Latch 2021, San Francisco (United States), Series A | Provider of a web-based platform for genomic bioinformatics | $33M | 60/100 | |
7th |  Transcripta Bio 2020, Palo Alto (United States), Series B | AI-powered platform for drug screening and development | $34M | 59/100 | |
8th |  BostonGene 2015, Waltham (United States), Series B | Developer of cloud-based information and analytics platform to treat cancer | $200M | 57/100 | |
9th |  Arpeggio 2017, Boulder (United States), Series B | Provider of drug discovery platform for the treatment of cancer | $49.5M | 55/100 | |
10th | Provider of gene biobanking database and services for research purposes | $45M | 54/100 | ||
148th |  Yuce Biotechnology 2015, Shenzhen (China), Series B | Developer of gene detection services for precise immunotherapy of tumors | - | 29/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Yuce Biotechnology's competitors? Click here to see the top ones
Yuce Biotechnology's Investments and acquisitions
Yuce Biotechnology has made no investments or acquisitions yet.
Reports related to Yuce Biotechnology
Here is the latest report on Yuce Biotechnology's sector:
News related to Yuce Biotechnology
•
Yuce Biotech Completes Pre-B+ Round of Financing of Tens of Millions of Yuan to Develop Early Screening and Diagnosis of Alzheimer's DiseasePEdaily•May 27, 2024•LH Ventures, Yuce Biotechnology
•
Yuce Biotechnology receives 300 million yuan in Series C financing, Yuanzhi Technology Medical leads the investmentPEdaily•Aug 25, 2020•Chinre, Puhua Capital, Yuce Biotechnology
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Yuce Biotechnology
Explore our recently published companies
- Nic Beddoe Insurance - Truckee based, Unfunded company
- Jerry Tench Insurance - San Francisco based, Unfunded company
- Cesar Carrillo Insurance - Island Lake based, Unfunded company
- Clinton Raines - Atlanta based, Unfunded company
- Brian Himmelman State Farm - Conifer based, Unfunded company
- Curt Sumpter State Farm - Silver Spring based, Unfunded company
